Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Myths and facts about pediatric cancer

"Your child has cancer." They are words every parent can't imagine hearing.

24 Apr 2010

New federally funded programs to address health disparities in underserved communities

The increasing number of minorities diagnosed with cancer has inspired a variety of initiatives at The University of Texas M. D. Anderson Cancer Center focusing on minority health through research, education and community relations.

24 Apr 2010

Programs to address care for children born with SCD during adulthood

Forty years ago, children born with sickle cell disease (SCD) were not expected to live past their teenage years. Today, medical advances are allowing children to live well into adulthood, raising concerns over who is going to care for these patients as adults. However, programs are underway to address these concerns, as reported in the March/April edition of Journal of Pediatric Oncology Nursing, published by the Association of Pediatric Hematology/Oncology Nurses (APHON).

24 Apr 2010

WellPoint responds to HHS letter on singling out women with breast cancer for rescission

I was disappointed to read your letter regarding the media report published in Reuters yesterday as well as your assertion that WellPoint "deliberately works to deny coverage for women diagnosed with breast cancer." Both your statement and Mr. Waas' piece are inaccurate and grossly misrepresent WellPoint's efforts to help prevent, detect, and treat the 1 in 8 of our 34 million members nationwide affected by breast cancer.

24 Apr 2010

Karolinska University Hospital acquires Leksell Gamma Knife Perfexion fifth generation radiosurgery system

Prof. Lars Leksell (1907-1986), inventor of the radiosurgical instrument that bears his name and a faculty member of Karolinska University Hospital (Solna, Sweden), performed the world's first Gamma Knife® surgery at nearby Sophiahemmet Hospital, the location of the first Leksell Gamma Knife. Karolinska University Hospital recently acquired Elekta's fifth generation radiosurgery system, Leksell Gamma Knife® Perfexion™.

24 Apr 2010

CAT may improve QOL in pediatric oncology patients undergoing therapy: Researchers

As health care professionals continue placing greater emphasis on the quality of life of childhood cancer patients, researchers have found that creative arts therapy may improve QOL in pediatric oncology patients undergoing therapy.

24 Apr 2010

New hopes to improve cancer diagnosis and treatment for children

Motivated clinicians and an Internet connection combined with computers and e-mail access have the power to transform pediatric cancer treatment in the most remote corners of earth, according to a St. Jude investigator writing in a recent issue of The Lancet Oncology.

24 Apr 2010

Moffitt Cancer Center reports increasing interest in ERCC1 Analysis test for selecting chemotherapy for NSCLC

Moffitt Cancer Center announces steadily growing interest in the ERCC1 Analysis, the first test developed for selecting chemotherapy for Non Small Lung Cancer patients. Each year, more than 200,000 Americans are diagnosed with lung cancer.

24 Apr 2010

Karolinska University Hospital acquires Elekta's fifth generation radiosurgery system

Prof. Lars Leksell (1907-1986), inventor of the radiosurgical instrument that bears his name and a faculty member of Karolinska University Hospital (Solna, Sweden), performed the world's first Gamma Knife surgery at nearby Sophiahemmet Hospital, the location of the first Leksell Gamma Knife. Karolinska University Hospital recently acquired Elekta's fifth generation radiosurgery system, Leksell Gamma Knife Perfexion.

24 Apr 2010

NREF announces fellowship funding for 2010-2011

The Neurosurgery Research and Education Foundation (NREF), which reached an agreement with Codman & Shurtleff, Inc. (Codman) in December 2009 to provide funding to the NREF in support of the Foundation's new post-residency, clinical fellowship grant program, is pleased to announce that the following programs have been awarded fellowship funding for 2010-2011: Baylor College of Medicine (pediatric neurosurgery), Brigham & Women's Hospital (general neurosurgery),

23 Apr 2010

EpiCept invites stockholders to attend Annual Meeting

With this notice, stockholders of EpiCept Corporation are invited to the Annual Meeting of Stockholders on June 3, 2010, at 10:00 a.m. Eastern time at the Dolce/IBM Palisades Executive Conference Center, 334 Route 9W, Palisades, New York 10964.

23 Apr 2010

European Patent Office intends to grant patent for Intezyne's IVECT Method

Intezyne today announced it has received notification the European Patent Office intends to grant a patent covering a key element of Intezyne's breakthrough drug delivery technology, the IVECT Method. At the core of this technology is the IVECT micelle, a proprietary, polymeric nanoparticle designed to encapsulate and deliver best-in-class therapeutics, while limiting exposure to healthy tissues.

23 Apr 2010

Astellas Pharma extends tender offer for OSI Pharmaceuticals

Astellas Pharma Inc. announced today that it has extended its all-cash tender offer for $52 per share for all of the currently outstanding shares of common stock (including the associated stock purchase rights) of OSI Pharmaceuticals, Inc. to 5:00 p.m. New York City time on Monday, May 17, 2010, unless further extended.

23 Apr 2010

Geron scientists highlight importance of telomerase inhibitor, GRN163L at AACR 2010

Geron Corporation today announced five presentations by Geron scientists and collaborators on the company's telomerase inhibitor, imetelstat sodium, including the drug's activity against cancer stem cells, at the 101st American Association for Cancer Research annual meeting held in Washington D.C.

23 Apr 2010

Medical groups adopt stricter ethics code against conflicts of interest

The Associated Press: A new ethics code adopted by leading medical groups on Wednesday is supposed to keep the drug and medical device industry from having too much financial influence over medical practitioners. "It's the most sweeping move ever taken by the Council of Medical Specialty Societies to curb conflict of interest — a growing concern as private industry bankrolls a greater share of medical research.

23 Apr 2010

Long-term monitoring of young leukaemia survivors necessary to identify declining lung health: Researchers

Children who have survived leukaemia may need to have regular monitoring to ensure their lungs remain healthy if they had a bone marrow transplantation during their treatment, US scientists have said.

23 Apr 2010

Genentech submits sBLA for Herceptin plus chemotherapy for advanced HER2-positive stomach cancer

Genentech, Inc., a wholly owned member of the Roche Group, announced today that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Herceptin® (trastuzumab) plus chemotherapy in people with advanced, HER2-positive adenocarcinoma of the stomach, including gastroesophageal junction cancer.

23 Apr 2010

BSD-2000 Hyperthermia System combined with chemotherapy promising for children with high-risk tumors

BSD Medical Corporation today reported clinical study data showing that hyperthermia, using the BSD-2000 Hyperthermia System, combined with chemotherapy has the potential to improve control rate and long-term survival for the treatment of children with high-risk cancer who have a dismal prognosis.

23 Apr 2010

RMEI, PIM jointly sponsor complimentary continuing education virtual lecture on CRPC

Castrate-refractory prostate cancer, which is characterized by tumor progression despite castrate levels of testosterone, develops in many prostate cancer patients treated with androgen-deprivation therapy. Standardized guidelines for the treatment of CRPC are lacking, and a number of factors must be considered when deciding between second-line hormonal therapy and chemotherapy.

23 Apr 2010

Data from pivotal study of Marqibo in ALL patients to be presented at ASCO meeting

Hana Biosciences, a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that complete data from its pivotal study of Marqibo in patients with relapsed/refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia, have been accepted for an oral podium presentation at the 46th Annual Meeting of the American Society of Clinical Oncology to be held June 4-8, 2010 in Chicago, Illinois.

23 Apr 2010

Oncology News and Research

Further Reading

Myths and facts about pediatric cancer

New federally funded programs to address health disparities in underserved communities

Programs to address care for children born with SCD during adulthood

WellPoint responds to HHS letter on singling out women with breast cancer for rescission

Karolinska University Hospital acquires Leksell Gamma Knife Perfexion fifth generation radiosurgery system

CAT may improve QOL in pediatric oncology patients undergoing therapy: Researchers

New hopes to improve cancer diagnosis and treatment for children

Moffitt Cancer Center reports increasing interest in ERCC1 Analysis test for selecting chemotherapy for NSCLC

Karolinska University Hospital acquires Elekta's fifth generation radiosurgery system

NREF announces fellowship funding for 2010-2011

EpiCept invites stockholders to attend Annual Meeting

European Patent Office intends to grant patent for Intezyne's IVECT Method

Astellas Pharma extends tender offer for OSI Pharmaceuticals

Geron scientists highlight importance of telomerase inhibitor, GRN163L at AACR 2010

Medical groups adopt stricter ethics code against conflicts of interest

Long-term monitoring of young leukaemia survivors necessary to identify declining lung health: Researchers

Genentech submits sBLA for Herceptin plus chemotherapy for advanced HER2-positive stomach cancer

BSD-2000 Hyperthermia System combined with chemotherapy promising for children with high-risk tumors

RMEI, PIM jointly sponsor complimentary continuing education virtual lecture on CRPC

Data from pivotal study of Marqibo in ALL patients to be presented at ASCO meeting

A best-practice guide for laboratory services in oncology trials eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News